Skip to content

PostEra

YC W20 · Active · Medicinal Chemistry powered by Machine Learning

Competitors

Adjacent

Also from W20 in AI

All of W20

About PostEra

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discovery effort; COVID Moonshot.

YC batch
W20 · Winter 2020
Status, per YC
Active
Category
AI
Team size
40
Location
Boston, MA, USA
Checked
32m ago

YC tags: AI-powered Drug Discovery, Machine Learning, COVID-19

PostEra in W20: 228 companies, 29% AI

PostEra: questions

Which YC batch was PostEra in?

PostEra was in Y Combinator's Winter 2020 batch (W20).

Is PostEra still active?

Y Combinator lists PostEra as active.

Where is PostEra based?

PostEra lists Boston, MA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.